Blisovi Fe 1 — Class II drug recall D-0638-2020
Terminated recall by Lupin Pharmaceuticals Inc., reported 2020-01-15, distributed nationwide. Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the bliste
| Recall number | D-0638-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2019-12-26 |
| Classified | 2020-01-03 |
| Reported by FDA | 2020-01-15 |
| Terminated | 2020-10-22 |
| Distributed | Nationwide (US) |
| NDC | 68180-0866-11 |
| Lot numbers | H801227 |
| Expiration dates | 2020-01-20 |
Product
Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals Inc Baltimore, MD 21202, Manufactured for: Lupin Limited Pithampur 454775 INDIA 240875, NDC 68180-866-11
Reason for recall
Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0638-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.